📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucose. (2014)

First Author: Tan TM

Attributed to: Developmental Clinical Studies - Curing Obesity with the 'Medical Bypass' funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/jc.2014-2143

PubMed Identifier: 25144632

Publication URI: http://europepmc.org/abstract/MED/25144632

Type: Journal Article/Review

Volume: 99

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 11

ISSN: 0021-972X